Postmenopausal Women Can Rely on Boniva Ibandronate to Treat Osteoporosis part 3

Like any other bisphosphonate drugs, the oral administration of  generic Boniva  ( Japanese : イバンドロン ) may cause upper gastrointestinal disorders like esophagitis (inflammation of the esophagus), dysphagia (difficulty or painful swallowing), and esophageal or gastric ulcer. The only way to minimize the risks associated with these disorders is to abide by the dosing guidelines closely. You should discontinue the medication if any new or aggravating symptoms come to the fore.

Before taking the medicine, tell your doctor if you're pregnant or plan to become pregnant during the treatment. The drug is listed in the FDA pregnancy category C. So, it is unknown whether Boniva causes harm to an unborn baby. In the same way, it is still unclear whether Boniva passes into breast milk and harms a nursing baby. Do not start using the medication without letting your physician know if you are breastfeeding a baby.